Zelda Therapeutics Ltd.
from OTCQB Podcast Hosted by OTC Markets Group
Richard Hopkins, the CEO of Zelda Therapeautics Ltd. (OTCQB: ZLDAF) an Australian-based bio-pharmaceutical company is focused on developing a range of cannabinoid-based medicines for the treatment of a variety of medical conditions. Richard joins the podcast to discuss the types of diseases and disorders Zelda is targeting.
Embed this episode
No transcript yet.
Similar podcasts
Frequently asked questions
How long is this episode of OTCQB Podcast?
This episode is 9 minutes long.
When was this OTCQB Podcast episode published?
This episode was published on October 2, 2019.
Can I download this OTCQB Podcast episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.